[Pharmacological testing of a new anti-inflammatory agent: 1-(m-trifluoromethylphenyl)-N-nitroso anthranilic acid].
D000284:Administration, Oral; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology*; D000927:Anticonvulsants / Q000494:pharmacology; D001341:Autonomic Nervous System / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D005439:Flufenamic Acid / Q000494:pharmacology; D005461:Fluorine / Q000494:pharmacology; D005769:Gastrointestinal Motility / Q000187:drug effects; D007408:Intestinal Absorption / Q000187:drug effects; D051379:Mice; D009603:Nitroso Compounds / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D014203:Tremorine / Q000037:antagonists & inhibitors; D062367:ortho-Aminobenzoates / Q000008:administration & dosage / Q000494:pharmacology*
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D009603:Nitroso Compounds; D062367:ortho-Aminobenzoates; D005461:Fluorine; D005439:Flufenamic Acid; D014203:Tremorine
Valutazione farmacological di un nuovo antiinfiammatorio: l'acido 1-(m-trifluorometilfenil)-N-nitroso antranilico.